Does how you start a glucose monitor matter? new study says maybe
NCT ID NCT05928572
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 159 adults with type 2 diabetes to see if the way they are introduced to a continuous glucose monitor (CGM) affects their blood sugar control. One group received a nutrition-focused approach, while the other used a self-directed method. The main goal was to measure time in range—the percentage of time blood sugar stays between 70 and 180 mg/dL. The study also examined diet quality and what happens when CGM use is paused for four months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
continuous glucose monitor (CGM) initiation approach
What this could lead to
If successful, this could show that a nutrition-focused introduction to CGM helps people with type 2 diabetes better manage their blood sugar levels.
What could go wrong
This is a small, completed study comparing two educational approaches, not testing a new drug or device. Results may not apply to everyone with type 2 diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HealthPartners Institute dba International Diabetes Center
Minneapolis, Minnesota, 55416, United States